Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-HX01 PET/CT in Soft Tissue Sarcoma
CTR20260647Phase 2Active
- Sponsor
- Hexin Pharmaceutical
- Start
- Apr 2026
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-HX01 in soft tissue sarcoma (STS), sponsored by Hexin Pharmaceutical. Started Apr 2026; status: active.
02
Drugs
68Ga-HX01
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on CTR20260647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260647.